Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Baylor College of Medicine
- Duke University
- Fred Hutchinson Cancer Center
- Stanford University
- University of Gdansk
- University of Washington
- Yale University
- CNRS
- Massachusetts Institute of Technology
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Florida
- University of Kentucky
- University of Minnesota
- Aarhus University
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Human Technopole
- Indiana University
- Institut Pasteur
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Macromolecular Chemistry CAS
- Lunds universitet
- Luxembourg Institute of Health
- MAYNOOTH UNIVERSITY
- Massachusetts Institute of Technology (MIT)
- Maynooth University
- Michigan State University
- Nencki Institute of Experimental Biology
- Pennsylvania State University
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- Rutgers University
- SUNY University at Buffalo
- St Jude Children's Research Hospital
- The Wistar Institute
- Umeå University
- University Hospital Magdeburg
- University of California San Diego - Ganesan Lab
- University of California, Los Angeles
- University of Colorado
- University of Kansas Medical Center
- University of Louisville
- University of Maryland, Baltimore
- University of Miami
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- Utrecht University
- Washington University in St. Louis
- 37 more »
- « less
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
of self-tolerance to the insulin producing beta cells, and 2) Development of immunotherapies for T1D. The work makes use of several genetically manipulated mouse models of T1D, as well as humanized mouse
-
, transplantation models, or advanced immunological techniques. Experience with vaccine development, immunotherapy, or translational immunology. Interest in translational research related to hematologic disorders
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on use of cancer specific T cells
-
Affairs. The FY27 minimum is $79, 056. Immunotherapies Targeting Pediatric AML Laboratory of Tanja Andrea Gruber, M.D., Ph.D. (Pediatrics, Stanford Cancer Institute) Division of Hematology Oncology Stem
-
in future immunotherapy and diagnostic applications. The raised antibodies will also be useful tools for cancer glycobiology studies. The prepared synthetic glycopeptide library will also be
-
immunotherapies. The successful candidate will play a pivotal role in modeling the complex tumor microenvironment and its dynamic interactions with therapeutic immune cells. While expertise in in vitro
-
and repair, and the roles of these pathways in cancer initiation, progression and response to chemotherapy and immunotherapy. We recently identified new pathways by which replication responds to DNA
-
immunology, T cell immunotherapy, and cytokine biology. This position offers the opportunity to pursue independent and collaborative research integrating classical immunology with cell and protein engineering
-
well as age-related neurological disorders such as Alzheimer’s disease (AD), and then to develop effective strategies for manipulation of T cell fate and function for disease prevention and immunotherapy
-
Research Center for Molecular Medicine (CeMM), ÖAW | Vienna, Virginia | United States | 2 months ago
CRISPR perturbation profiling. Tissue immunology, immunotherapy, cell engineering, and/or synthetic biology (Bock Lab , CeMM/MedUni Vienna). We develop and apply innovative technologies for analyzing